Quality of life and its influencing factors in children and adolescents with congenital adrenal hyperplasia

YU Li-rong; DU Xiang-ping; WU Xian; YUAN Yi; YANG Yu; YU Zhen

doi:10.11852/zgetbjzz2020-2141

PDF(730 KB)

Chinese Journal of Child Health Care ›› 2021, Vol. 29 ›› Issue (8) : 843-847. DOI: 10.11852/zgetbjzz2020-2141

Original Articles

Quality of life and its influencing factors in children and adolescents with congenital adrenal hyperplasia

YU Li-rong, DU Xiang-ping, WU Xian, YUAN Yi, YANG Yu, YU Zhen

Author information +

History +

Abstract

Objective To investigate the quality of life and its influencing factors in children and adolescents with congenital adrenal hyperplasia(CAH),so as to provide evidence for improving their quality of life. Methods From January 2013 to December 2018,a total of 48 children and adolescents with CAH aged 5 to 18 years in Jiangxi Provincial Children's Hospital and their parents were investigated by using the Pediatric Quality of Life Inventory Measurement Models 4.0(PedsQL4.0).Meanwhile 119 healthy children and adolescents aged 5 to 18 years and their parents were selected as control group.SPSS 22.0 software was used for statistical analysis. Results Significant differences existed between CAH children and healthy controls in social function(self-report:t=2.711,caregivers proxy-report:t=3.048),school performance(self-report: t=2.718,caregivers proxy-report: t=4.671),social psychological function(self-report: t=3.674,caregivers proxy-report: t=5.587)and total scores(self-report: t=4.026,caregivers proxy-report: t=5.342)(P<0.05).There was no significant difference in health-related quality of life between male and female children and adolescents with CAH(P>0.05).The scores of each domain of PedsQL in CAH children and adolescents with poor hormone control,complications and no regular follow-up were significantly lower than those in the normal control group(P<0.05).CAH children who were older and with longer course had lower scores in each domains. Conclusions The quality of life of children and adolescents with CAH is significantly impaired,especially in children and adolescents with poor hormone control,complications,no regular follow-up,long course of disease and old age,which needs more attention from society and family.

Key words

children and adolescents / congenital adrenal hyperplasia / PedsQL / quality of life

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

YU Li-rong, DU Xiang-ping, WU Xian, YUAN Yi, YANG Yu, YU Zhen. Quality of life and its influencing factors in children and adolescents with congenital adrenal hyperplasia[J]. Chinese Journal of Child Health Care. 2021, 29(8): 843-847 https://doi.org/10.11852/zgetbjzz2020-2141

References

[1] Ginalska-Malinowska M.Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency-the next disease included in the neonatal screening program in Poland[J].Dev Period Med,2018,22(2):197-200.
[2] Bourdeau I,Salle SPL,Lacroix A.Adrenocortical hyperplasia:A multifaceted disease[J].Best Pract Res Clin Endocrinol Metab,2020,34(3):101386.
[3] Daae E,Feragen KB,Nermoen I,et al.Psychological adjustment,quality of life,and self-perceptions of reproductive health in males with congenital adrenal hyperplasia:a systematic review[J].Endocrine,2018,62(1):3-13.
[4] Gidlöf S,Falhammar H,Thilén A,et al.One hundred years of congenital adrenal hyperplasia in Sweden:a retrospective,population-based cohort study[J].Lancet Diabetes Endocrinol,2013,1(1):35-42.
[5] Speiser PW,Arlt W,Auchus RJ,et al.Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency:an endocrine society clinical practice guideline[J].J Clin Endocrinol Metab,2018,103(11):4043-4088.
[6] Nordenstrom A,Falhammar H.Management of endocrine disease:diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency[J].Eur J Endocrinol,2019,180(3):127-145.
[7] 中华医学会儿科学分会内分泌遗传代谢病学组.先天性肾上腺皮质增生症21-羟化酶缺陷诊治共识[J].中华儿科杂志,2016,54(8):569-576.
[8] Musa N,Asem N,Basyony S,et al.Assessment of health-related quality of life in Egyptian children and adolescents with congenital adrenal hyperplasia[J].J Pediatr Endocrinol Metab,2020,33(2):295-304.
[9] Gilban DLS,Alves Junior PA,Beserra ICR,et al.Health related quality of life of children and adolescents with congenital adrenal hyperplasia in Brazil[J].Health Qual Life Outcomes,2014,12:107.
[10] Vijayan R,Bhavani N,Pavithran PV,et al.Metabolic profile,cardiovascular risk factors and health-related quality of life in children,adolescents and young adults with congenital adrenal hyperplasia[J].J Pediatr Endocrinol Metab,2019,32(8):871-877.
[11] Falhammar H,Frisen L,Hirschberg AL,et al.Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency:a Swedish population-based national cohort study[J].J Clin Endocrinol Metab,2015,100(9):3520-3528.
[12] Bouvattier C,Esterle L,Renoult-Pierre P,et al.Clinical outcome,hormonal status,gonadotrope axis,and testicular function in 219 adult men born with classic 21-hydroxylase deficiency.A French national survey[J].J Clin Endocrinol Metab,2015,100(6):2303-2313.
[13] Jenkins-Jones S,Parviainen L,Porter J,et al.Poor compliance and increased mortality,depression and healthcare costs in patients with congenital adrenal hyperplasia[J].Eur J Endocrinol,2018,178(4):309-320.
[14] Engels M,Gehrmann K,Falhammar H,et al.Gonadal function in adult male patients with congenital adrenal hyperplasia[J].Eur J Endocrinol,2018,178(3):285-294.
[15] Falhammar H,Frisén L,Norrby C,et al.Reduced frequency of biological and increased frequency of adopted children in males with 21-hydroxylase deficiency:a Swedish population-based national cohort study[J].J Clin Endocrinol Metab,2017,102(11):4191-4199.
[16] El-Maouche D,Arlt W,Merke DP.Congenital adrenal hyperplasia[J].Lancet,2017,390(10108):2194-2210.
[17] Turcu AF,Auchus RJ.Novel treatment strategies in congenital adrenal hyperplasia[J].Curr Opin Endocrinol Diabetes Obes,2016,23(3):225-232.
[18] Zainuddin AA,Grover SR,Ghani NAA,et al.Health-related quality of life of female patients with congenital adrenal hyperplasia in Malaysia[J].Health Qual Life Outcomes,2020,18(1):258.
[19] Improda N,Barbieri F,Ciccarelli GP,et al.Cardiovascular health in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxilase deficiency[J].Front Endocrinol(Lausanne),2019,10:212.
[20] Yau M,Vogiatzi M,Lewkowitz-Shpuntoff A,et al.Health-related quality of life in children with congenital adrenal hyperplasia[J].Horm Res Paediatr,2015,84(3):165-171.
[21] Engberg H,Butwicka A,Nordenström A,et al.Congenital adrenal hyperplasia and risk for psychiatric disorders in girls and women born between 1915 and 2010:a total population study[J].Psychoneuroendocrinology,2015,60:195-205.